Skip to main content
TipRanks
Go Ultimate75% OFF

BridgeBio Pharma (BBIO) Income Statement

1,538 Followers

BridgeBio Pharma Income Statement

Last quarter (Q3 2026), BridgeBio Pharma's total revenue was $353.17M, an increase of 192.60% from the same quarter last year. In Q3, BridgeBio Pharma's net income was $-56.71M. See BridgeBio Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 502.08M$ 221.90M$ 9.30M$ 77.65M$ 69.72M
$ 473.81M$ 218.02M$ 6.86M$ 74.21M$ 66.60M
$ 1.04B$ 811.00M$ 614.23M$ 586.42M$ 643.23M
Depreciation and Amortization$ 5.43M$ 6.08M$ 6.49M$ 6.77M$ 5.84M
$ -676.45M$ -436.83M$ -565.47M$ -397.44M$ -533.83M
$ -569.09M$ -592.97M$ -607.37M$ -512.20M$ -576.63M
$ -165.90M$ 50.78M$ -45.88M$ 27.55M$ -9.82M
$ -734.99M$ -542.19M$ -653.25M$ -484.65M$ -586.45M
$ -729.31M$ -535.76M$ -643.20M$ -481.18M$ -562.54M
Per Share Metrics
Basic EPS$ -3.79$ -2.88$ -3.95$ -3.35$ -3.90
Diluted EPS$ -3.79$ -2.88$ -3.95$ -3.35$ -3.90
Weighted Average Shares Outstanding197.24M186.08M162.79M147.47M144.36M
Weighted Average Shares Outstanding (Diluted)197.24M186.08M162.79M147.47M144.36M

Currency in USD

BridgeBio Pharma Earnings and Revenue History

-1.2B-600M0600M-7500 %-5000 %-2500 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin